PubMed=23161805; DOI=10.1002/emmm.201201973; PMCID=PMC3569650
Jacquet L., Stephenson E.L., Collins R., Patel H., Trussler J., Al-Bedaery R., Renwick P.J., Ogilvie C.M., Vaughan R., Ilic D.
Strategy for the creation of clinical grade hESC line banks that HLA-match a target population.
EMBO Mol. Med. 5:10-17(2013)

PubMed=26607962; DOI=10.1038/srep17258; PMCID=PMC4660465
Canham M.A., Van Deusen A.L., Brison D.R., De Sousa P.A., Downie J.M., Devito L.G., Hewitt Z.A., Ilic D., Kimber S.J., Moore H.D., Murray H., Kunath T.
The molecular karyotype of 25 clinical-grade human embryonic stem cell lines.
Sci. Rep. 5:17258.1-17258.13(2015)

PubMed=27345806; DOI=10.1016/j.scr.2015.12.036; PMCID=PMC4757724
Devito L.G., Wood V., Kadeva N., Cornwell G., Codognotto S., Stephenson E.L., Ilic D.
Generation of KCL039 clinical grade human embryonic stem cell line.
Stem Cell Res. 16:170-172(2016)

PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative p53 mutations.
Nature 545:229-233(2017)